Back to company

OBA-PHARMA ApS: Financial statements 2014

CVR: 19995607

OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,664,804 and a net result of DKK 3,119,719 compared with DKK 2,356,113 the year before. That is an increase of 26.3% compared with the year before. Equity amounted to DKK 3,598,404. The solvency ratio was 54.9%.

Gross Profit
3,664,804 kr.
Profit/Loss
3,119,719 kr.
Equity
3,598,404 kr.
Total Assets
6,553,510 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-3.7 mio.3.1 mio.3.6 mio.-
2013-2.9 mio.2.4 mio.3 mio.-
2012-3 mio.2.2 mio.7.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on OBA-PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

OBA-PHARMA ApS: The 2013 annual report is outJan 17, 2014

OBA-PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 2,900,864, and the net result was DKK 2,356,113.

About OBA-PHARMA ApS

OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees. In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity amounted to DKK 674,251.